Age and sex or gender (sex/gender) and HIV vaccine preparedness (Q30202232)

10 June 2017

Age and sex or gender (sex/gender) and HIV vaccine preparedness (English)

1 reference

10 June 2017

0 references

0 references

1

Shayesta Dhalla

1 reference

10 June 2017

29 October 2015

1 reference

Psychology, Health and Medicine

10 June 2017

1 reference

10 June 2017

1-20

1 reference

Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials

10 June 2017

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Adolescents and HIV vaccine trials: what are the clinical trial site issues?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Knowledge and attitudes towards HIV vaccines among Soweto adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

HIV-1 virion-cell interactions: an electrostatic model of pathogenicity and syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Negative social impacts among volunteers in an HIV vaccine efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in HIV-1 vaccine trials among young Thai men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Trends in diagnoses of HIV infection in the United States, 2002-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Enrollment and retention of HIV discordant couples in Lusaka, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in future HIV prevention trials in Beira, Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

HIV vaccine trials: will intravenous drug users enroll?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Correlates of HIV vaccine trial participation: an Indian perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness of Chinese injection drug users to participate in HIV vaccine trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Factors Associated with Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users and Young Gay and Bisexual Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2015.1093646

10.1080/13548506.2015.1093646

21 January 2018

Identifiers

DOI

0 references

PubMed ID

26515031

1 reference

PubMed ID

26515031